Preparation and pharmacokinetics in beagle dogs of ganershu sustained‑release pellets

ABSTRACT

Background: The active ingredients of Ganershu compound recipe, which are effective for hepatitis treatment in liver protection and transaminase reduction. However, the active ingredients of Ganershu compound recipe are poor absorption, which conduct it has a low oral bioavailability. Objective: We prepared Ganershu sustained‑release pellets (GSPs) by fluidized‑bed on central composite design‑response surface methodology and increase its bioavailability in beagle dogs. Materials and Methods: In this study, GSPs were successfully prepared. The Drug‑loaded pellets and sustained‑release coated were carried out in fluidized‑bed machine. GSP was optimized for fitting release, roundness, and the overall desirability by central composite design‑response surface methodology. Results: To optimize cumulative release profile, the outermost ethyl cellulose coating layer and the hydroxypropyl methyl cellulose (HPMC) swelling layer were employed, which were respectively given coating levels in terms of weight gain of 22% and 6%, the concentration of HPMC is 4.5% (g/ml). The pharmacokinetics of Ganershu normal pellets (GNPs) and GSP was studied in beagle dogs after oral administration. The naringenin as an index, the area under the curve0‑∞ of naringenin in GSP was 1.38 times greater than that of GNP. Meanwhile, Tmax of GSP was prolonged for about 74%. Conclusion: This study can clearly indicate that we enhanced the oral bioavailability of Ganershu by preparing the GSP, which had the sustained dissolution and improved the potential of it for clinical application.

KEYWORDS

• Beagle dogs
• fluidized‑bed
• Ganershu sustained‑release pellets
• naringenin
• pharmacokinetics

Showing references and in-text citations exactly as published.

• DOI10.4103/0973-1296.137360Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 10, ISSUE 39Direct proof by 13C‑nuclear magnetic resonance of semi‑purified extract and isolation of ent‑Catechin from leaves of Eucalyptus cinereaSayonara Mendes Silva, Simone Yae Abe, Fernanda Giacomini Bueno, Norberto Peporine Lopes, João Carlos Palazzo de Mello, Tomoe Nakashima · pp. 191–194Original ArticleSame type: Article
• Article · VOLUME 10, ISSUE 39Simultaneous determination of four neuroprotective compounds of Tilia amurensis by high performance liquid chromatography coupled with diode array detectorBohyung Lee, Jin Bae Weon, Bo‑Ra Yun, Jiwoo Lee, Min Rye Eom, Choong Je Ma · pp. 195–199Original ArticleSame type: Article
• Article · VOLUME 10, ISSUE 39Comparison of toad skins Bufo bufo gargarizans Cantor from different regions for their active constituents content and cytotoxic activity on lung carcinoma cell linesCongyan Liu, Wei Cao, Yan Chen, Ding Qu, Jing Zhou · pp. 207–212Original ArticleSame type: Article
• Article · VOLUME 10, ISSUE 39New Sesquiterpene and Polymethoxy‑Flavonoids from Artemisia annua LYang Chu, Hongbo Wang, Jing Chen, Yue Hou · pp. 213–216Original ArticleSame type: Article